Multimodal therapy for acute and chronic venous thrombotic and occlusive disease.
Critical deep venous thrombosis and occlusion constitutes a small percentage of patients with venous disease. However, these patients exhibit severe symptomatology including pain and extensive edema that may progress to limb- or life-threatening complications such as phlegmasia cerulea dolens and superior vena cava syndrome. This paper reviews the different multimodal percutaneous interventions currently available for the treatment of complex critical venous thrombotic and occlusive disease.
Chaer
Rabih A
RA
Department of Surgery, Division of Vascular Surgery, The New York-Presbyterian Hospital, Weill Medical College of Cornell University, New York, NY 10021, USA.
Dayal
Rajeev
R
Lin
Stephanie C
SC
Trocciola
Susan
S
Morrissey
Nicholas J
NJ
McKinsey
James
J
Kent
K Craig
KC
Faries
Peter L
PL
D000208:Acute Disease; D017130:Angioplasty; D000925:Anticoagulants / Q000627:therapeutic use; D019917:Blood Vessel Prosthesis Implantation; D002908:Chronic Disease; D003131:Combined Modality Therapy; D005121:Extremities / Q000098:blood supply* / Q000473:pathology / Q000601:surgery; D006801:Humans; D015607:Stents; D013479:Superior Vena Cava Syndrome / Q000209:etiology / Q000517:prevention & control; D017131:Thrombectomy; D015912:Thrombolytic Therapy; D013924:Thrombophlebitis / Q000209:etiology / Q000517:prevention & control; D014680:Veins / Q000473:pathology / Q000601:surgery; D016306:Vena Cava Filters; D020246:Venous Thrombosis / Q000150:complications / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*
D000925:Anticoagulants